Fangfang Li, Zongliang Liu, Heyuan Sun, Chunmei Li, Wenyan Wang, Liang Ye, . . . Hongbo Wang. (2020). PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression in vitro and in vivo. Elsevier.
Chicago Style (17th ed.) CitationFangfang Li, Zongliang Liu, Heyuan Sun, Chunmei Li, Wenyan Wang, Liang Ye, Chunhong Yan, Jingwei Tian, and Hongbo Wang. PCC0208017, a Novel Small-molecule Inhibitor of MARK3/MARK4, Suppresses Glioma Progression In vitro and In vivo. Elsevier, 2020.
MLA (9th ed.) CitationFangfang Li, et al. PCC0208017, a Novel Small-molecule Inhibitor of MARK3/MARK4, Suppresses Glioma Progression In vitro and In vivo. Elsevier, 2020.
Warning: These citations may not always be 100% accurate.